RSV in Acute Respiratory Infection Surveillance Among Community-Dwelling Elderly Aged ≥50 Years in China

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorHuashan Hospital

About this trial

This is a multicenter, prospective, observational, community-based study designed to evaluate the incidence of respiratory syncytial virus (RSV) infection among community-dwelling elderly individuals in China, as well as their cohabiting older adults and children, over a 24-month period. During the study, home visits will be conducted to collect nasopharyngeal (NP) swabs from all community residents aged ≥50 years who report symptoms of acute respiratory infection (ARI). Pathogen detection will be performed using both point-of-care testing (POCT) and centralized laboratory analysis.

Eligibility criteria

Qualifiers

Male or female adults aged ≥50 years (calculated based on date of birth and date of visit).

At least two respiratory symptoms/signs within 48 hours prior to self-reporting OR

At least one respiratory symptom/sign + one systemic symptom/sign within 48 hours prior to self-reporting

Provision of written informed consent by the participant or their legal guardian, in accordance with local EC (Ethics Committee) requirements.

Disqualifiers

Enrollment in the CRE-ARI group within the preceding 14 days.

Enrollment in the CRE-ARI group has been more than 4 times during the previous 12 months (applicable only to the CRE-ARI group enrollment).

For CAI group, if a household has been enrolled into CAI group within the previous 12 months.

Residence outside the designated study catchment area.

Trial design

Treatments tested in this trial

  • NP swabs

Treatment groups

28,800 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Huashan Hospital

Lead sponsor

Shanghai Huashen Institute of Microbes and Infections

Collaborator